<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We determined whether the epidermal growth factor receptor (EGFR) <z:chebi fb="0" ids="38637">tyrosine kinase inhibitor</z:chebi> (TKI) N-​(3-​chlorophenyl)-​6,​7-​dimethoxy-​4-​quinazolinamine (tyrphostin AG-1478) causes <z:hpo ids='HP_0002917'>hypomagnesemia</z:hpo> and cardiac dysfunction in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Tyrphostin was administered (3 times per week, intraperitoneal injection, to achieve 21.4 mg·(kg body mass)(-1)·day(-1)) to normomagnesemic rats for 5 weeks </plain></SENT>
<SENT sid="2" pm="."><plain>Levels of <z:chebi fb="131" ids="25107">magnesium</z:chebi> in the plasma of the tyrphostin-treated rats decreased significantly by the following amount: 17% at week 1, 27% at week 2, and 26%-35% between weeks 3 to 5 </plain></SENT>
<SENT sid="3" pm="."><plain>Levels of the plasma <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation marker <z:chebi fb="0" ids="33023">8-isoprostane</z:chebi> rose significantly: by 58% at week 1, 168% at week 3, and 113% at week 5 </plain></SENT>
<SENT sid="4" pm="."><plain>At week 5, blood neutrophils from the tyrphostin-treated group displayed a 2.26-fold higher basal level of <z:chebi fb="0" ids="15379">O(2)</z:chebi>(·-) generation; the ratio of oxidized <z:chebi fb="0" ids="16856">glutathione</z:chebi> (<z:chebi fb="0" ids="17858">glutathione disulfide</z:chebi>; GSSG) to reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) in the red blood cells increased 2.5-fold </plain></SENT>
<SENT sid="5" pm="."><plain>At week 5, echocardiography revealed that TKI treatment resulted in significant cardiac systolic dysfunction, with impaired diastolic function and <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Since <z:hpo ids='HP_0002917'>hypomagnesemia</z:hpo> alone can trigger <z:mp ids='MP_0003674'>oxidative stress</z:mp> and cardiac injury, we suggest that inhibition of EGFR-TK caused <z:chebi fb="131" ids="25107">magnesium</z:chebi> <z:mp ids='MP_0005150'>wasting</z:mp>, which partly contributed to decreased cardiac contractility </plain></SENT>
</text></document>